pipette
ESEspañol

Whole-blood NAD levels track cardiovascular disease but not chronological age

Diana Romenskaja-Avgul, Deimantė Stakelytė, Audrius Laurynėnas, Eimantas Ramonas, Rūta Zabitaitė, Simona Cibulskė, Sigita Danilevičienė, Rapolas Danilevičius, Kristina Ratautė, Marius Dagys, Dalius Ratautas

Peer-reviewed journalEasy to read

In the authors' words

Abstract The extent to which whole-blood NAD levels are altered in human disease or ageing remains controversial. Here we conducted 1,340 measurements in 1,068 adults, and found that whole-blood NAD levels do not decline with age in healthy individuals; they remain stable in males and increase in females, but are reduced in chronic diseases, specifically cardiovascular disease and hypertension. These findings indicate that whole-blood NAD levels track cardiovascular disease rather than chronological age. As this research was not designed to investigate causality, these data do not provide direct evidence that NAD supplementation may serve as a treatment for cardiovascular disease or hypertension.

Main resultLimitation the authors admit

Appeared: Friday, November 6. Nature Metabolism. Peer-reviewed journal.

DOI: 10.1038/s42255-026-01660-3